160 related articles for article (PubMed ID: 9839120)
1. Vanadyl sulfate does not enhance insulin action in patients with type 1 diabetes.
Aharon Y; Mevorach M; Shamoon H
Diabetes Care; 1998 Dec; 21(12):2194-5. PubMed ID: 9839120
[No Abstract] [Full Text] [Related]
2. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.
Goldfine AB; Patti ME; Zuberi L; Goldstein BJ; LeBlanc R; Landaker EJ; Jiang ZY; Willsky GR; Kahn CR
Metabolism; 2000 Mar; 49(3):400-10. PubMed ID: 10726921
[TBL] [Abstract][Full Text] [Related]
3. Mixing insulin lispro and ultralente insulin.
Bastyr EJ; Holcombe JH; Anderson JH; Clore JN
Diabetes Care; 1997 Jun; 20(6):1047-8. PubMed ID: 9167130
[No Abstract] [Full Text] [Related]
4. Long- term efficacy and safety of vanadium in the treatment of type 1 diabetes.
Soveid M; Dehghani GA; Omrani GR
Arch Iran Med; 2013 Jul; 16(7):408-11. PubMed ID: 23808778
[TBL] [Abstract][Full Text] [Related]
5. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
Fugono J; Yasui H; Sakurai H
J Pharm Pharmacol; 2005 May; 57(5):665-9. PubMed ID: 15901357
[TBL] [Abstract][Full Text] [Related]
6. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
[TBL] [Abstract][Full Text] [Related]
7. Dose-response relationship of insulin glulisine in subjects with type 1 diabetes.
Becker RH; Frick AD; Nosek L; Heinemann L; Rave K
Diabetes Care; 2007 Oct; 30(10):2506-7. PubMed ID: 17675541
[No Abstract] [Full Text] [Related]
8. [Flexible intensive insulin therapy: a change in mentalities].
Penfornis A; Chabroux S; Grimaldi A
Rev Med Interne; 2008 Nov; 29(11):857-60. PubMed ID: 18387717
[No Abstract] [Full Text] [Related]
9. Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients.
Davidson MB; Dulan S; Duran P; Bazargan M
Diabetes Care; 2004 Sep; 27(9):2260-1. PubMed ID: 15333498
[No Abstract] [Full Text] [Related]
10. Glucose response to intense aerobic exercise in type 1 diabetes: maintenance of near euglycemia despite a drastic decrease in insulin dose.
Mauvais-Jarvis F; Sobngwi E; Porcher R; Garnier JP; Vexiau P; Duvallet A; Gautier JF
Diabetes Care; 2003 Apr; 26(4):1316-7. PubMed ID: 12663620
[No Abstract] [Full Text] [Related]
11. The Scylla and Charybdis of blood glucose control in children with diabetes mellitus.
Sperling MA
J Pediatr; 1997 Mar; 130(3):339-41. PubMed ID: 9063403
[No Abstract] [Full Text] [Related]
12. Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats.
Dehghani GA; Ahmadi S; Omrani GR
Indian J Med Res; 1997 Nov; 106():481-5. PubMed ID: 9415745
[TBL] [Abstract][Full Text] [Related]
13. Optimizing glycemic control with insulin glargine.
Williams JB
Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
[No Abstract] [Full Text] [Related]
14. Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen.
Mohn A; Strang S; Wernicke-Panten K; Lang AM; Edge JA; Dunger DB
Diabetes Care; 2000 Apr; 23(4):557-9. PubMed ID: 10857953
[No Abstract] [Full Text] [Related]
15. Brain-derived neurotrophic factor and insulin resistance during hyperinsulinaemic-euglycaemic clamp in type 1 diabetes patients in the PoProStu.
Uruska A; Niedzwiecki P; Araszkiewicz A; Zozulinska-Ziolkiewicz D
Diabetes Metab; 2017 Oct; 43(5):472-474. PubMed ID: 28139435
[No Abstract] [Full Text] [Related]
16. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats.
Tunali S; Yanardag R
Pharmacol Res; 2006 Mar; 53(3):271-7. PubMed ID: 16431126
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous glucagon-like peptide I combined with insulin normalizes postcibal glycemic excursions in IDDM.
Dupré J; Behme MT; Hramiak IM; McDonald TJ
Diabetes Care; 1997 Mar; 20(3):381-4. PubMed ID: 9051391
[No Abstract] [Full Text] [Related]
18. The circadian study: the get-up phenomenon in type 1 diabetes.
Freckmann G; Jovanovic L; Baumstark A; Haug C; van der Helm W
Diabetes Care; 2008 Nov; 31(11):e85. PubMed ID: 18955712
[No Abstract] [Full Text] [Related]
19. Insulin Pumps.
Pickup JC
Diabetes Technol Ther; 2018 Feb; 20(S1):S30-S40. PubMed ID: 29437475
[No Abstract] [Full Text] [Related]
20. New Insulin Options for Diabetic Patients.
Van Klompenburg E; Heins JR
S D Med; 2016 Feb; 69(2):84-5. PubMed ID: 26999916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
